Lisata Therapeutics (LSTA) has provided an update.
Lisata Therapeutics, Inc. has recently shared its financial outcomes for the second quarter of 2024, which concluded on June 30. To keep investors and industry observers informed, the company released a press statement and provided a slide presentation for upcoming conferences. This information, while made public, is not considered officially filed under securities law, nor is it intended for incorporation into any legal filings related to the Securities Act, except where explicitly stated.
For an in-depth examination of LSTA stock, go to TipRanks’ Stock Analysis page.
